Aclarion Inc

Aclarion Inc specializes in diagnostic imaging systems. Specifically, they develop the NOCISCAN Suite, a non-invasive cardiac imaging solution designed to evaluate coronary artery disease and myocardial perfusion. The system uses advanced imaging algorithms to visualize blood flow and cardiac function without requiring invasive procedures.

Aclarion Inc is headquartered in the United States. The company’s focus on developing diagnostic imaging technology is centered around this location.

The NOCISCAN Suite is listed in the eudamed registry, which is the European database for medical devices. This registry tracks devices authorized for use within the European Union.

The NOCISCAN Suite falls under Class I classification in the EU. This classification is typically assigned to low-risk medical devices, such as diagnostic imaging systems with minimal risk to patients when used as intended.